ICL vs BIOX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Apr 01, 2026

ICL

58.2
AI Score
VS
ICL Wins

BIOX

52.2
AI Score

Investment Advisor Scores

ICL

58score
Recommendation
HOLD

BIOX

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ICL BIOX Winner
Forward P/E 55.5556 14.9925 BIOX
PEG Ratio 9.44 1.9521 BIOX
Revenue Growth 6.2% -16.4% ICL
Earnings Growth 1.7% 34.4% BIOX
Tradestie Score 58.2/100 52.2/100 ICL
Profit Margin 3.2% -17.7% ICL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, ICL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.